According to the World Health Organization, roughly one-third of patients diagnosed with plaque psoriasis is younger than 20 years of age, and adolescents in particular have limited treatment options.
Specialty Pharmacy News
Verzenio works by blocking certain molecules that are involved in cancer cell growth, and it joins two previously approved drugs in this class — palbociclib (Pfizer’s Ibrance) and ribociclib (Novartis’ Kisqali).
The new indication’s approval marks the 10th new indication for Keytruda in three years, Merck said.
Temptime VP global customer development Christopher Caulfield spoke with Drug Store News about how the company’s tools helps pharmacies deliver value to patients and the healthcare system.
The Distinguished Service Award is given annually to an individual who has made a sustained contribution to leadership within NASP and the specialty pharmacy industry.
Mvasi, a biosimilar of Avastin, is indicated to treat five types of cancer.
Kåre Schultz Schultz has had a nearly 30-year career in the pharmaceutical and healthcare industries, including a long stint at Novo Nordisk, where he eventually became COO.